PHARMACYTE BIOTECH, INC. Cash
PHARMACYTE BIOTECH, INC. (PMCB) had Cash of $72.64 million as of 2023-01-31, per its 10-Q filed 2023-03-16.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2023-03-16
- 2023-01-31: Cash $72.64M.
- 2022-10-31: Cash $76.96M.
- 2022-07-31: Cash $82.23M.
- 2022-04-30: Cash $85.40M.
| Period end | Cash |
|---|---|
| 2023-01-31 | $72.64M 10-Q · filed 2023-03-16 |
| 2022-10-31 | $76.96M 10-Q · filed 2022-12-14 |
| 2022-07-31 | $82.23M 10-Q · filed 2022-09-14 |
| 2022-04-30 | $85.40M 10-Q · filed 2023-03-16 |
| 2022-01-31 | $86.64M 10-Q · filed 2022-03-15 |
| 2021-10-31 | $86.94M 10-Q · filed 2021-12-14 |
| 2021-07-31 | $959.27K 10-Q · filed 2021-09-14 |
| 2021-04-30 | $2.20M 10-K · filed 2022-07-28 |
| 2021-01-31 | $3.09M 10-Q · filed 2021-03-12 |
| 2020-10-31 | $3.72M 10-Q · filed 2021-12-14 |
| 2020-07-31 | $2.17M 10-Q · filed 2021-09-14 |
| 2020-04-30 | $894.86K 10-Q · filed 2021-12-14 |
| 2020-01-31 | $142.24K 10-Q · filed 2021-03-12 |
| 2019-10-31 | $45.06K 10-Q · filed 2020-12-11 |
| 2019-07-31 | $327.75K 10-Q · filed 2020-09-11 |
| 2019-04-30 | $515.25K 10-K · filed 2021-08-10 |
| 2019-01-31 | $699.46K 10-Q · filed 2020-03-13 |
| 2018-10-31 | $907.42K 10-Q · filed 2019-12-23 |
| 2018-07-31 | $1.83M 10-Q · filed 2019-09-13 |
| 2018-04-30 | $1.06M 10-K · filed 2020-08-13 |
| 2018-01-31 | $1.51M 10-Q · filed 2019-03-14 |
| 2017-10-31 | $2.68M 10-Q · filed 2018-12-14 |
| 2017-07-31 | $4.28M 10-Q · filed 2018-09-12 |
| 2017-04-30 | $3.46M 10-K · filed 2019-08-13 |
| 2017-01-31 | $2.46M 10-Q · filed 2018-03-19 |
| 2016-10-31 | $1.55M 10-Q · filed 2017-12-14 |
| 2016-07-31 | $2.34M 10-Q · filed 2017-09-13 |
| 2016-04-30 | $1.92M 10-K · filed 2018-07-20 |
| 2016-01-31 | $2.86M 10-Q · filed 2017-03-13 |
| 2015-10-31 | $2.31M 10-Q · filed 2016-12-02 |
| 2015-07-31 | $2.91M 10-Q · filed 2016-09-06 |
| 2015-04-30 | $2.70M 10-K · filed 2017-07-27 |
| 2015-01-31 | $958.82K 10-Q · filed 2016-03-08 |
| 2014-10-31 | $1.16M 10-Q/A · filed 2016-01-19 |
| 2014-07-31 | $2.90M 10-Q/A · filed 2016-01-19 |
| 2014-04-30 | $3.62M 10-K · filed 2016-07-29 |
| 2014-01-31 | $864.89K 10-Q · filed 2014-03-17 |
| 2013-10-31 | $396.59K 10-Q · filed 2013-12-16 |
| 2013-07-31 | $206.04K 10-Q · filed 2014-09-15 |
| 2013-04-30 | $199.30K 10-K · filed 2016-07-29 |
| 2013-01-31 | $33.33K 10-Q · filed 2014-03-17 |
| 2012-10-31 | $22.70K 10-Q · filed 2013-12-16 |
| 2012-07-31 | $24.34K 10-Q · filed 2012-09-19 |
| 2012-04-30 | $15.72K 10-K/A · filed 2016-01-19 |
| 2012-01-31 | $39.08K 10-Q · filed 2012-03-21 |
| 2011-10-31 | $14.51K 10-Q · filed 2011-12-15 |
| 2011-07-31 | $83.07K 10-Q/A · filed 2011-09-20 |
| 2011-04-30 | $57.20K 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |